Nurix Therapeutics Announces Presentations at the American
Nurix to report additional preclinical data for its targeted BTK degraders NX-2127 and NX-5948...
Globe Newswire15-03-2023, 03:58
Brand Strategy Firm Founder, Professor and Speaker Sasha 18-02-2023, 11:41